Cargando…

Levosimendan preconditioning in patients undergoing elective cardiac surgery with poor ejection fraction. preliminary results.

Detalles Bibliográficos
Autores principales:	Ávalos, R, MartinezSanz, R, Jiménez, JJ, Iribarren, JL, Montoto, J, Lacruz, A, Brouard, M, Garrido, P, Prada, PC, Pérez, Jorge P, García-González, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695710/ http://dx.doi.org/10.1186/1749-8090-10-S1-A310

Ejemplares similares

Aortic root full detachment from the aortic annulus. aortitis role in the formation of a pseudoaneurysm to 3 years of an aortic valve replacement.
por: MartinezSanz, R, et al.
Publicado: (2015)

Alternatives in the treatment of prosthetic infection after the Bentall-de Bono operation.
por: MartinezSanz, R, et al.
Publicado: (2015)

Factors related to permanent disability employment on patients fewer than 62 years operated by open heart surgery
por: MartinezSanz, R, et al.
Publicado: (2015)

Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy
por: Jiménez-Rivera, Juan José, et al.
Publicado: (2020)

Levosimendan in patients with low ejection fraction undergoing cardiac surgery
por: Kucewicz-Czech, Ewa M., et al.
Publicado: (2018)

Safety and effectiveness of different treatment regimes with tranexamic acid in elective cardiopulmonary bypass patients
por: Iribarren, JL, et al.
Publicado: (2011)

A Randomized Pilot Trial of Remote Ischemic Preconditioning in Heart Failure with Reduced Ejection Fraction
por: McDonald, Michael A., et al.
Publicado: (2014)

Effects of levosimendan started 24 hours before cardiopulmonary bypass in patients admitted to the ICU with an ejection fraction lower than 30%
por: Duchateau, J, et al.
Publicado: (2009)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Concordance analysis of left ventricular mass by transthoracic echocardiography versus 64-slice multidetector computed tomography
por: Jimenez, JJ, et al.
Publicado: (2011)

Coronary artery disease and differential analysis of a valve calcium score by transthoracic echocardiography
por: Iribarren, JL, et al.
Publicado: (2011)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Interaction between etomidate and beta tumoral necrosis factor on hemodynamic response after cardiac surgery
por: Iribarren, JL, et al.
Publicado: (2015)

Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)
por: Caruba, Thibaut, et al.
Publicado: (2016)

Global longitudinal strain value for predicting left ventricular remodeling after primary percutaneous reperfusion therapy in acute myocardial infarction
por: Jiménez, JJ, et al.
Publicado: (2015)

Metabolic syndrome and coronary artery bypass graft surgery
por: Brouard, M, et al.
Publicado: (2011)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study
por: Chan, Cze-Ci, et al.
Publicado: (2021)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
por: Matan, Dmitri, et al.
Publicado: (2022)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Fast permutation preconditioning for fractional diffusion equations
por: Wang, Sheng-Feng, et al.
Publicado: (2016)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery – a retrospective analysis
por: Grieshaber, Philippe, et al.
Publicado: (2016)

Levosimendan in Right Ventricular Dysfunction
por: Kapoor, Mukul C.
Publicado: (2023)

Preconditioning by isoflurane as a volatile anesthetic in elective coronary artery bypass surgery
por: Kiani, Amjad, et al.
Publicado: (2013)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Myocardial Protecting Role of Glutamine in Patients with Low Ejection Fraction Undergoing Elective On-Pump Coronary Artery Bypass Graft Surgery
por: Parmana, I Made Adi, et al.
Publicado: (2022)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
por: Nauta, J. F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5p82bc9kr5ollfv24qae062l1m